We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Method Enables Precise Detection of Nanoplastics in Body

By LabMedica International staff writers
Posted on 03 Sep 2025

Nanoplastic particles, with diameters under 0. More...

001 millimeters, can penetrate body tissue and accumulate in organs. Because they are difficult to detect precisely, research into the health impacts of microplastics and nanoplastics (MNP) has remained challenging. A new approach now enables the reliable tracking of these particles from ingestion to the cellular level, providing the first detailed insights into their behavior within the body.

The new method, developed by researchers from MedUni Vienna (Vienna, Austria) and the University of Hamburg (Hamburg, Germany), as well as collaborators, combines three analytical techniques. These include inductively coupled plasma mass spectrometry (ICP-MS) for quantification, X-ray fluorescence imaging (XFI) for localizing particles in tissue, and imaging mass cytometry (IMC) for mapping distribution at the cellular level. By labeling nanoplastics with palladium, the team enabled detailed tracking of their fate in the body.

Mouse models were tested under three exposure conditions: single short-term intake, medium-term exposure over ten days, and long-term exposure over five weeks. The findings, published in Nature Communications Biology, showed that most particles are excreted quickly after one intake, but prolonged exposure led to accumulation in organs such as the liver, kidneys, and brain. In mice with impaired intestinal barriers or altered intestinal movement, excretion slowed, increasing tissue uptake.

The new method provides both quantitative and spatial analyses of nanoplastics, overcoming limitations of earlier approaches. This allows researchers to more accurately investigate potential health risks linked to chronic exposure. The technique can help clarify how these particles interact with biological systems, laying the groundwork for future studies on long-term health effects and possible preventive measures.

“The significance of our study lies less in these biological observations themselves than in the development of a methodological approach that combines quantitative and spatial analyses for the first time,” said Lukas Kenner, Clinical Department of Pathology, MedUni Vienna.

Related Links:
MedUni Vienna
University of Hamburg


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
Sample Transportation System
Tempus1800 Necto
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.